Gilead Sciences: all 734 studies

Page 8 of 8. Open to participants first (33), then studies with results posted, then the rest; newest registration first within each.

• Safety Study of 90Y-hMN14 to Treat Pancreatic CancerCompletedNCT00041639Phase 1/2
• Safety Study of 90Y-hMN14 to Treat Colorectal CancerCompletedNCT00040599Phase 1/2
• A 14-Day Study of Racivir When Used in Combination in HIV-Infected MalesCompletedNCT00040300Phase 1
• A Study of DPC 817 in HIV-Infected MalesCompletedNCT00040274Phase 1
• A Dose Escalation Study of Tenofovir Alafenamide in Treatment-Naive PatientsCompletedNCT00036634Phase 1/2
• Tenofovir Disoproxil Fumarate (TDF) in HIV-1 Patients Who Have Never Taken Anti-HIV DrugsCompletedNCT00016588Not applicable
• Tenofovir Disoproxil Fumarate in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drug CombinationsStatus unknownNCT00011089Not applicable
• The Safety of Tenofovir Disoproxil Fumarate Taken With Other Anti-HIV Drugs to Treat HIV-Infected PatientsStatus unknownNCT00007436Phase 3
• Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's LymphomaStatus unknownNCT00003338Phase 2/3
• Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's LymphomaStatus unknownNCT00003337Phase 3
• A Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV InfectionCompletedNCT00002453Not applicable
• Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected PatientsCompletedNCT00002450Phase 3
• The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDSCompletedNCT00002437Phase 2
• A Study on the Safety and Effectiveness of Adefovir Dipivoxil in Combination With Anti-HIV Therapy (HAART) in HIV-Positive PatientsCompletedNCT00002426Not applicable
• Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor TreatmentCompletedNCT00002419Phase 2
• Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected PatientsCompletedNCT00002415Phase 2
• Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug CombinationsCompletedNCT00002398Not applicable
• The Safety and Effectiveness of PMPA Prodrug in HIV-Infected PatientsStatus unknownNCT00002396Phase 1
• A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDSStatus unknownNCT00002384Not applicable
• The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV DrugsCompletedNCT00002379Phase 2
• The Safety and Effectiveness of Bis-POM PMEA in HIV-Infected PatientsCompletedNCT00002346Phase 1
• The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected PatientsCompletedNCT00002327Phase 1
• The Safety and Effectiveness of Zidovudine Plus Adefovir in HIV-Infected PatientsCompletedNCT00002326Phase 1
• Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected PatientsCompletedNCT00002234Phase 2
• Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected ChildrenStatus unknownNCT00002219Phase 2
• A Study of Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Been Treated With Anti-HIV DrugsCompletedNCT00002206Phase 1
• A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected PatientCompletedNCT00002184Phase 2
• Cidofovir as a Treatment for Herpes Simplex in Patients With AIDSCompletedNCT00002181Not applicable
• A Study of PMPA in HIV-Infected PatientsCompletedNCT00002180Phase 1
• A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3CompletedNCT00002161Not applicable
• An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDSCompletedNCT00002142Not applicable
• Phase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected PatientsCompletedNCT00002128Phase 1
• A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDSCompletedNCT00002116Phase 1
• A Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of 9-(2-Phosphonylmethoxyethyl)Adenine ( PMEA; Adefovir ) in Patients With Advanced HIV Disease.CompletedNCT00002115Phase 1

← Gilead Sciences overview and focus areas